Huntlardo
Posted - 25 minutes ago
$GERN forth time hitting this 4.14-4.16 range and bouncing off it. this is the floor.
rtornatore13
Posted - 3 hours ago
$GERN weird
Rickster4retirement
Posted - 4 hours ago
$GERN Unless this is some type of setup, this downward pressure with approval is really bothersome 👺
bonksofla
Posted - 5 hours ago
$GERN sure does look like the powers to be want to close that gap down at around $4.05 before earnings, maybe this week. We will see soon.
signet01
Posted - 6 hours ago
$GERN stinking YH would not publish the following inoffensive comment… ”No one, in their right mind, having held on for some number of years, would let go now, when RYTELO is about to reach its promise to patients and long-term shareholders… “
AxelWiz
Posted - 7 hours ago
$GERN idiots shorting a sure thing with fda approval! wow
UnlikelyResult
Posted - 8 hours ago
$GERN Where's the next catalyst here?
G101SPM
Posted - 8 hours ago
@Cello69 #SYMBOLBOX Hold long position $GERN $4.15 bid. DAC (dollar average cost) $3.30 (3.14.24) carries SPM 86.15 tag to EXIT( $8.50).
G101SPM
Posted - 8 hours ago
@Cello69 #SYMBOLBOX Hold long position $GERN $4.15 bid. DAC (dollar average cost) $3.30 (3.14.24) carries SPM 86.15 tag to EXIT( $$8.50).
stefano62
Posted - 8 hours ago
$GERN actually we are really nont able to see two green days in arow........ this is frustrating
patso1964
Posted - 9 hours ago
$GERN this is just ridiculous we are approved and there are people seling for penny
ZoeyTanner
Posted - 9 hours ago
The best short in the business $GERN
DAWGNuts
Posted - 3 days ago
$GERN there was a huge short position when newly hired Geron execs were hired. Do you think Scarlett and company with punish shorts for helping them get their cheap shares? That's a hard no imo.
Cello69
Posted - 3 days ago
$GERN What's with this pig?
telomerase
Posted - 3 days ago
$GERN more competition in the anti-telomerase field, and it's finished Phase 2. Oncolys, a Japanese company: https://www.oncolys.com/en/
DoctrBenway
Posted - 3 days ago
@Egerton Dear Dr. Osler: As you're an oncologist dealing with AML, MDS, etc. I thought I'd get your opinions on Rytelo (imetelstat, $GERN) and Xpovio (selinexor, $KPTI). I've also followed if you want to take it to IMs. Best regards, Wm Welch. 😀
chrlapp
Posted - 4 days ago
$GERN C’mon, EMA. Bring Rytelo to Europe.
DAWGNuts
Posted - 4 days ago
$GERN Baker Bros in the building!(Behind the curtains)
Huntlardo
Posted - 5 days ago
$GERN shorts are trying hard to keep a cap on this
Huntlardo
Posted - 5 days ago
$GERN lowest volume day in a long time
FreshFit
Posted - 5 days ago
$GERN buy 4.20 sell at 4.60 has been the cycle lol
Night_Owl_Biotech
Posted - 5 days ago
$SWTX is trading at a year to date low after reporting its second quarterly beat in a row 2 months ago. SWTX shot up after reporting the Q2 2024 beat but is off roughly 28% since (over the last 6-7 weeks). Investors may want to consider SWTX's 2 near-term therapies both of which are anticipated to be Blockbusters (per SWTX's CEO & BofA analysts). We are not qualified to opine on these estimates so we recommend investors research for themselves. Considering Big Pharma's are losing key patents, many believe M&A will eventually pick up. As near as we can tell, SWTX is one of a few high quality targets with meaningful near term revenue pot'l. SWTX trades for ~2.0X FY28 (Year 4) analyst consensus revenue estimates. Centerview Partners' review per IMGN's 14A filing notes median peer Year 4 M&A multiples at 6.0X. SWTX may or may not be a peer. Other comm'l stage oncology focused bios are trading at lows (i.e. $IOVA, $DAWN, $GERN $URGN). This is not investment advice but is it time?
patso1964
Posted - 5 days ago
$GERN Gern state that they expect to spend $280 Mil next FY 800 patients at 365K/y is $792 Mil this stock is just getting ready to make $$$$$$$$$$$$$$$$$$$$$$$$$$
Mail_Dog
Posted - 5 days ago
$GERN While SHs continue to wait for EMA-MAA…
patso1964
Posted - 5 days ago
$GERN pure manipulation someone is keeping this down
Huntlardo
Posted - 5 days ago
$GERN https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=a69f1432-af4c-471b-88c8-44c7c81587aa&ccId=19000101_000001&type=JS&lang=en_US&jobId=519269 • Owns and manages the publication planning process and Phase 4 program identification, prioritization, and reviews with cross-functional teams Wonder if we get a conditional approval with MF and phase four study too confirm. Language in this job description would lead one to believe so. BP pulled this link
KingCryptoMan
Posted - 5 days ago
$GERN For everyone living in the Tampa Bay region like me - Now is the time for prayers. The beach communities are a catastrophe from hurricane Helene. Homes and businesses destroyed. Milton is barreling down. I wish everyone God Speed.
Percy619
Posted - 6 days ago
$GERN i can't believe i'm up a hundred thirty nine percent in a year and there's not enough action.